83 studies found for:
"Fabry disease"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
The Efficacy and Safety of Switch Between Agalsidase Beta to Agalsidase Alfa for Enzyme Replacement in Patients With Anderson-Fabry Disease
|
||||
| 2 | Recruiting |
Fabry Disease Registry
|
||||
| 3 | Recruiting |
Androgenetic Alopecia in Fabry Disease
|
||||
| 4 | Recruiting |
Establishment of Biomarkers for Fabry Disease
|
||||
| 5 | Completed |
Data Collection in Women With Fabry Disease
|
||||
| 6 | Recruiting |
Pulmonary Disease and Exercise Tolerance in Boys With Fabry Disease
|
||||
| 7 | Completed |
PET Scans in Normal Volunteers and Patients With Fabry Disease
|
||||
| 8 | Completed |
Alpha-Galactosidase A Replacement Therapy for Fabry Disease
|
||||
| 9 | Recruiting |
Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease
|
||||
| 10 | Completed |
Alternative Dosing and Regimen of Replagal to Treat Fabry Disease
|
||||
| 11 | Recruiting |
A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease
|
||||
| 12 | Completed |
An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry Disease
|
||||
| 13 | Completed |
Dosing Study of Replagal in Patients With Fabry Disease
|
||||
| 14 | Completed |
Replagal Enzyme Replacement Therapy for Adults With Fabry Disease
|
||||
| 15 | Completed |
A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry Disease
|
||||
| 16 | Completed |
Replagal Enzyme Replacement Therapy for Children With Fabry Disease
|
||||
| 17 | Completed |
Registry of Fabry Disease - A Multicenter Observational Study
|
||||
| 18 | Completed |
Drug-Drug Interaction Study Between AT1001 and Agalsidase in Subjects With Fabry Disease
|
||||
| 19 | Active, not recruiting |
Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease
|
||||
| 20 | Active, not recruiting |
Open Label Long-term Safety Study of AT1001 in Patients With Fabry Disease Who Have Completed a Previous AT1001 Study
|
† Indicates status has not been verified in more than two years
